Who makes Lavior Diabetic Wound Gel?

Lavior Diabetic Wound Gel is developed by Lavior Pharma Inc..

What development phase is Lavior Diabetic Wound Gel in?

Lavior Diabetic Wound Gel is in Phase 2.

Last reviewed 2026-05-15 · How we verify

Lavior Diabetic Wound Gel

Lavior Pharma Inc. · Phase 2 active Small molecule

At a glance

Generic name	Lavior Diabetic Wound Gel
Sponsor	Lavior Pharma Inc.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Restoring Tissue and Evaluating Novel Treatments for Efficacy in Wounds (PHASE2, PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Lavior Diabetic Wound Gel CI brief — competitive landscape report
Lavior Diabetic Wound Gel updates RSS · CI watch RSS
Lavior Pharma Inc. portfolio CI